Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year.
IN8bio Provides Update From The Ongoing Phase 1 Clinical Trial Of Its Allogeneic Gamma-Delta T Cell Therapy In Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant
The ongoing Phase 1 trial of INB-100 is the first and most clinically advanced program administering large systemic doses of allogeneic gamma-delta T cells to patients
3 patients have been
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 11)
20 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
5 Stocks To Watch For September 13, 2021
Some of the stocks that may grab investor focus today are:
Wall Street expects Oracle Corporation (NYSE: ORCL) to report quarterly earnings at $0.97 per share on revenue of $9.77 billion after the closing bell. Oracle shares fell 0.1% to $89.64 in after-hours trading.
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 26)
